Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Clinical Significance and Characterization of Streptococcus tigurinus Isolates in an Adult Population

Lori Bourassa, J. E. Clarridge III
E. Munson, Editor
Lori Bourassa
aDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. E. Clarridge III
aDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA
bVeterans Administration Puget Sound Health Care System, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Munson
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01551-15
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Streptococcus tigurinus is a newly described member of the Streptococcus mitis group. Due to the difficulty in distinguishing viridans group streptococci (VGS) by phenotype, analysis of 16S rRNA sequences is necessary for the accurate identification of most species. Through a laboratory policy of analyzing all clinically significant isolates from the VGS group by16S rRNA gene sequencing, we identified 14 S. tigurinus isolates from 11 patients. The Vitek 2 system most commonly gave an excellent rating to an incorrect identification (e.g., Streptococcus mitis), as did matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) (e.g., Streptococcus oralis). S. tigurinus strains were recovered from numerous body sites, including the blood, peritoneal fluid, bone, synovial fluid, a perianal abscess, and an arm wound. Retrospective chart review indicated that most isolates were clinically significant, with bacteremia (n = 5), soft tissue infections (n = 3) osteomyelitis (n = 2), infected joint prosthesis (n = 2), and peritonitis (n = 2) being the most common, thus expanding the spectrum of disease associated with S. tigurinus.

INTRODUCTION

Streptococcus tigurinus was first described after isolation from a patient with infective endocarditis. Isolates of alpha-hemolytic, catalase-negative Gram-positive cocci were recovered from multiple blood cultures of a 74-year-old patient. The isolates were initially identified as viridans group streptococci (VGS). However, analysis of 16S rRNA sequences revealed that the isolates were distinct members of the Streptococcus mitis group (SMG) and were closely related to Streptococcus pneumoniae, Streptococcus pseudopneumoniae, Streptococcus mitis, Streptococcus infantis, and Streptococcus oralis (1). This novel Streptococcus strain was named Streptococcus tigurinus. Since the first report of S. tigurinus infection in 2012, S. tigurinus has been isolated from several additional sterile sites, including cerebrospinal fluid, heart valves, and joint fluid (2, 3). It has been associated with serious invasive infections, including infective endocarditis, culture-negative endocarditis, spondylodiscitis, bacteremia, meningitis, prosthetic joint infections, and thoracic empyema (2, 4). Small colony variants of S. tigurinus were associated with a prosthetic joint infection (3). S. tigurinus has also been isolated from the subgingival plaque of a patient with periodontitis (5). In vitro studies have shown S. tigurinus to be highly virulent in a rat model of experimental endocarditis (6).

Because of its relatedness to SMG, S. tigurinus has been hypothesized to be a commensal of the human oral cavity. Data to support this hypothesis, however, are conflicting (7). In a screen of saliva specimens from 31 volunteers, S. tigurinus was not identified among the more than 600 strains of alpha-hemolytic bacterial colonies isolated (2). In a second study that used a specific 16S rRNA gene real-time TaqMan PCR assay, however, S. tigurinus was detected in the saliva and subgingival plaque of 53% of patients sampled. S. tigurinus was not associated with periodontal disease in this study (8). Thus, the prevalence of S. tigurinus in the human oral cavity and the role of oral S. tigurinus in causing invasive infection warrant further investigation (7).

Due to the difficulty in differentiating members of the SMG using conventional and commercial phenotypic test methods, our laboratory analyzes all clinically significant isolates of SMG by16S rRNA gene sequencing. Through 16S sequencing, our laboratory identified 14 S. tigurinus isolates from 11 patients. The phenotypic characteristics and clinical significance of these isolates were investigated in this study.

MATERIALS AND METHODS

This study was completed with the Puget Sound Veterans Administration Medical Center institutional review board approval (MIRB 01012).

Bacterial strains.Fourteen isolates of S. tigurinus were isolated during routine culture procedures at the VA Puget Sound Healthcare System in Seattle, Washington. Isolates stored between 2000 and 2012 were from a randomly saved collection. However, after better recognition of S. tigurinus, we identified the 6 most recent patients in a 2.5-year period. Specimens were routinely cultured on sheep blood agar (SBA), chocolate agar, and MacConkey agar (Remel, Lenexa, KS). VGS colonies were identified using the biochemical- and sequencing-based approaches discussed below. Isolates were stocked at −70°C using an alphanumeric labeling system. All stocked clinical isolates were grown on sheep blood agar at 35°C in air enriched with 6% to 7% CO2.

Biochemical differentiation.Biochemical tests were performed with the Vitek 2 GP ID card and the Vitek 2 microbial identification system following the manufacturer's recommendations (bioMérieux, Durham, NC). Briefly, each S. tigurinus strain was subbed from a frozen stock onto SBA and passaged on SBA twice prior to analysis. Bacterial suspensions were made in a 0.9% sodium chloride solution and adjusted to a McFarland standard of 0.50 to 0.63 before testing with the GP ID card.

16S rRNA gene sequencing.The identity of the isolates was determined by 16S rRNA gene sequencing. Strains were subcultured from freezer stocks onto SBA and were incubated aerobically for 24 h. The DNA was extracted by using a Prepman apparatus (PE Applied Biosystems, Foster City, CA) following the manufacturer's instructions. Primers (synthesized by TIB Molbiol, Adelphia, NJ) VAB1 (5′-TGGAGAGTTTGATCCTGGCTCAG-3′) and VAB2 (5′-GTATTACCGCGGCTGCTGG-3′) were used to generate a 543-bp amplicon of the 16S rRNA gene. PCR was performed as previously described (9), and sequencing reactions were performed using the ABI Prism BigDye Terminator cycle sequencing kit (Applied Biosystems, Foster City, CA, USA), with sequences generated using the Biosystems 3500 genetic analyzer, according to the manufacturer's instructions. The sequences were analyzed and compared to information in the BIBI and GenBank databases (10). The phylogenetic tree was constructed with MUSCLE, a program for generating multiple alignments (11), with MEGA 5.1 software (http://www.megasoftware.net/).

Matrix-assisted laser desorption ionization–time of flight mass spectrometry analysis.Twelve S. tigurinus isolates were analyzed by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). For analysis, a portion of a single colony of each isolate was applied to a polished steel MSP 96-target plate as a thin film using a sterile wooden stick and analyzed using the MicroFlex LT mass spectrometer and database v3.3 (Bruker Daltonics, Billerica, MA), as previously described (12).

Antibiotic susceptibility testing.The antibiotic susceptibility testing of all isolates was determined using disk diffusion methods on Mueller-Hinton agar with 5% sheep blood, as recommended by the Clinical and Laboratory Standards Institute (CLSI), or using a Gram-positive panel on the Trek Sensititre (Thermo Scientific, Oakwood Village, OH). CLSI interpretive criteria for viridans group Streptococcus species were used.

RESULTS

By 16S rRNA gene sequencing, 14 alpha-hemolytic Streptococcus isolates from 11 patients were found to be identical or to have greater than 99.4% similarity to the type strain of S. tigurinus (i.e., DSM 24864) and approximately 98.5% similarity to Streptococcus cristatus and Streptococcus sanguis (Fig. 1). The published sequence of the S. tigurinus type strain differs by 13 bp of about 500 from S. mitis, and our strains differ by 0 to 3 bp from the type strain. The most variable 2-bp difference occurred between approximately bp 200 to 202.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Unrooted tree showing the phylogenetic relationships of the S. tigurinus strains isolated at the VA Medical Center to closely related species. The tree was inferred from 16S rRNA gene sequences by using the neighbor-joining method. The scale bar indicates the substitution rate per nucleotide. Sequences for all strains other than S. tigurinus were acquired from the GenBank database. Names and ATCC accession numbers are those cited in the GenBank database. Sequences for all S. tigurinus strains included in the dendrogram were generated by sequencing the first approximately 500-bp portion of the 16S rRNA gene at the Puget Sound VA Medical Center, Seattle, WA.

Strains of S. tigurinus identified in this study formed small, smooth, white to gray, alpha-hemolytic and nonhemolytic colonies on sheep blood agar, similar to many VGS. None of the strains were correctly identified by phenotypic methods. Biochemical and MALDI-TOF MS identification of the isolates was not successful. The Vitek 2 microbial identification system gave scores of excellent or very good identification as S. mitis or S. oralis for 8 of the isolates tested (66.7%) and a low discrimination identification for the remaining 4 isolates tested (33.3%), even though all identifications were incorrect (Table 1). S. tigurinus is not in the Vitek 2 database. MALDI-TOF MS was also used to identify each isolate. As spectra for S. tigurinus are not in the Bruker or the Vitek MS databases (13), the Bruker MALDI-TOF MS misidentified all of the isolates tested, usually as Streptococcus oralis (Table 1).

View this table:
  • View inline
  • View popup
TABLE 1

Identifications given by the bioMérieux Vitek 2 microbial identification system and the Bruker MALDI-TOF MSa

The clinical significance of recovery of S. tigurinus from each patient was determined through retrospective chart review. Patient demographic information, sites of isolation, and clinical findings are summarized in Table 2. All isolates of S. tigurinus were isolated from male patients, with a mean age of 60.8 years and an age distribution of 26 to 81 years of age. S. tigurinus strains were recovered from numerous body sites, including the blood (n = 5) and peritoneal fluid (n = 2), and 2 isolates each were associated with osteomyelitis and prosthetic joint infection. S. tigurinus was recovered in 3 soft tissue infections, including a perianal abscess, purulent cellulitis on an arm following trauma, and an arm wound at the site of intravenous drug administration. S. tigurinus represented the only organism isolated in 6 cases (55%). In other cases, it was recovered as a predominant species along with other organisms, including Enterococcus spp., other Streptococcus spp., and Leptotrichia wadei, a fastidious Gram-negative rod that is part of the normal human oral and intestinal flora (14). Leukocytosis was evident in 5 patients at the time of specimen collection, with inflammatory cells seen at the site of infection for 4 additional patients (Table 2).

View this table:
  • View inline
  • View popup
TABLE 2

A Summary of Patient Data and the Clinical Significance of Isolates of S. tigurinus

Four of the five patients with S. tigurinus bacteremia had significant comorbidities, including neutropenia, presence of a prosthetic joint, alcoholic cirrhosis, diabetes, and end-stage renal disease. A fifth patient with S. tigurinus bacteremia, patient 5, had no significant comorbidities but was emergently intubated 1 day prior to development of symptoms (fever, elevated WBCs) following anaphylactic shock from the administration of intravenous contrast. One of the patients with S. tigurinus bacteremia, patient 3, developed both paraspinal and epidural abscesses, and all four specimens were positive for S. tigurinus as the only organism. As Gram-positive cocci were seen in pleural fluid, the epidural abscesses were attributed to possible hematogenous spread of S. tigurinus from an oral site. S. tigurinus was isolated from the peritoneal fluid of 2 patients (patients 4 and 6). S. tigurinus was also isolated from the knee joint of a patient who underwent a knee revision arthroplasty 5 months prior (patient 7).

S. tigurinis was isolated from nonsterile sites in four patients (Table 2). In one patient, S. tigurinus was isolated from a wrist abscess at the site of illegal drug injection (patient 8); in a second patient, S. tigurinus was isolated from exudate collected from the anterior arm following trauma (patient 9). S. tigurinus was isolated along with Peptostreptococcus anaerobius in a patient with a recurrent perianal abscess (patient 10) and with Streptococcus anginosus from toe bone tissue in a patient with peripheral neuropathy (patient 11).

Antibiotic susceptibility results were available for 8 patients in this study (Table 3). Of those that were tested, all strains were susceptible to vancomycin and penicillin and all except strain F7522 were susceptible to levofloxacin. As shown, there was variable resistance to erythromycin, clindamycin, and tetracycline.

View this table:
  • View inline
  • View popup
TABLE 3

Antibiotic susceptibility of the S. tigurinus isolates identified in this studya

GenBank accession numbers.Strains F5643, F8301, F2513, F6347, F1811, and F6903 have been submitted to GenBank with accession numbers KT382194, KT382195, KT382196, KT382197, KT382198, and KT382199, respectively.

DISCUSSION

Although SMG isolates are commonly oral flora, our data suggest that the gastrointestinal tract and/or skin might also be sources from which S. tigurinus can access sterile sites and cause infection. In this study, seeding from oral sources is probable for 6 cases and possible for 2 more. Recent dental procedures or significant tooth decay were noted in the medical records for 4 of the 11 patients (36%). In addition, one patient was emergently intubated 24 h prior to isolation of S. tigurinus from blood specimens. It is possible that oral flora was introduced into the patient's bloodstream during the intubation procedure. Likewise, an aspiration event in one patient may have introduced S. tigurinus into the bloodstream. S. tigurinus was isolated from a patient who admitted to injecting drugs into his wrist several days before the development of the abscess. While not documented for this patient, it is possible the patient licked a needle prior to its use for injection of illicit drugs. One study estimated that one-third of injection drug users lick their needles prior to injecting (15). The skin could also have been a source of infection in this patient.

For the 2 patients who were diagnosed with peritonitis, the source of S. tigurinus was probably intestinal rather than oral. Spontaneous bacterial peritonitis (SBP) has been proposed to occur following a disturbance in the gut flora. This disturbance allows for overgrowth and translocation of enteric bacteria, typically Gram-negative enteric bacteria (16–18). Cirrhosis also predisposes an individual to overgrowth of bacterial flora and may lead to increased intestinal permeability (19, 20). Deficiencies of local immune response in patients with liver cirrhosis may also contribute to the development of SBP. The most frequent infection in patients with cirrhosis and ascites is SBP (19). The two patients with peritonitis in this study were documented to have cirrhosis and/or ascites. Thus, we cannot exclude the possibility that the intestine was the source of infection for these patients. The gastrointestinal tract was also the probable source of infection for the patient with a perianal abscess. Skin may have been the source of S. tigurinus for a patient with cellulitis and for a patient with chronic ulceration and osteomyelitis of a toe.

Accurate identification of S. tigurinus remains a challenge. S. tigurinus is not contained in the database for the Vitek 2 microbial identification system. As S. tigurinus spectra are not present in either of the currently available Biotyper (Bruker) or Vitek MS (bioMérieux) databases, S. tigurinus is not reliably identified by the most commonly used MALDI-TOF MS systems at this time (13). Currently, sequencing methods must be used to successfully identify S. tigurinus. Although our isolates were identified as S. tigurinus using standard procedures (21), there was sequence microheterogeneity of 2 bp in the 200-bp region of the 16S rRNA gene sequence. We detected no association between a particular sequence and a clinical condition.

In summary, using 16S rRNA gene sequencing, our laboratory identified 14 isolates of S. tigurinus from 11 patients and demonstrated that the usual methods of identification, MALDI-TOF MS and phenotypic biochemical testing, would not have correctly identified the organism. This study expands the spectrum of infection that can be attributed to S. tigurinus and suggests there are sources of S. tigurinus in addition to the oral mucosa. Our study adds to the growing body of literature demonstrating that S. tigurinus can cause severe, invasive infection and enlarges the spectrum of disease associated with this organism. To our knowledge, this is the first report of isolation of S. tigurinus from peritoneal fluid and a perianal abscess. Furthermore, including this report, 4 prosthetic joint infections caused by S. tigurinus have been described, highlighting the need for future studies on S. tigurinus biofilm formation (2, 3). As we are able to identify and describe the clinical significance of more of the VGS, we may find there are sufficient differences to warrant routine species-level identification of clinically significant isolates and to warrant improvements in the databases to do so.

ACKNOWLEDGMENTS

We thank the personnel of the microbiology laboratory at Veterans Administration Puget Sound Health Care System, especially Janelle Lee and Uyen Bui, for their support.

FOOTNOTES

    • Received 8 June 2015.
    • Returned for modification 7 July 2015.
    • Accepted 30 August 2015.
    • Accepted manuscript posted online 9 September 2015.
  • Copyright © 2015, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Zbinden A,
    2. Mueller NJ,
    3. Tarr PE,
    4. Sproer C,
    5. Keller PM,
    6. Bloemberg GV
    . 2012. Streptococcus tigurinus sp. nov., isolated from blood of patients with endocarditis, meningitis, and spondylodiscitis. Int J Syst Evol Microbiol 62:2941–2945. doi:10.1099/ijs.0.038299-0.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Zbinden A,
    2. Mueller NJ,
    3. Tarr PE,
    4. Eich G,
    5. Schulthess B,
    6. Bahlmann AS,
    7. Keller PM,
    8. Bloemberg GV
    . 2012. Streptococcus tigurinus, a novel member of the Streptococcus mitis group, causes invasive infections. J Clin Microbiol 50:2969–2973. doi:10.1128/JCM.00849-12.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Zbinden A,
    2. Quiblier C,
    3. Hernandez D,
    4. Herzog K,
    5. Bodler P,
    6. Senn MM,
    7. Gizard Y,
    8. Schrenzel J,
    9. Francois P
    . 2014. Characterization of Streptococcus tigurinus small-colony variants causing prosthetic joint infection by comparative whole-genome analyses. J Clin Microbiol 52:467–474. doi:10.1128/JCM.02801-13.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Kanamori H,
    2. Kakuta R,
    3. Yano H,
    4. Suzuki T,
    5. Gu Y,
    6. Oe C,
    7. Inomata S,
    8. Aoyagi T,
    9. Hatta M,
    10. Endo S,
    11. Tokuda K,
    12. Weber DJ,
    13. Nakamura Y,
    14. Saiki Y,
    15. Kaku M
    . 2015. A case of culture-negative endocarditis due to Streptococcus tigurinus. J Infect Chemother 21:138–140. doi:10.1016/j.jiac.2014.08.014.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Dhotre SV,
    2. Mehetre GT,
    3. Dharne MS,
    4. Suryawanshi NM,
    5. Nagoba BS
    . 2014. Isolation of Streptococcus tigurinus: a novel member of Streptococcus mitis group from a case of periodontitis. FEMS Microbiol Lett 357:131–135. doi:10.1111/1574-6968.12519.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Veloso TR,
    2. Zbinden A,
    3. Andreoni F,
    4. Giddey M,
    5. Vouillamoz J,
    6. Moreillon P,
    7. Zinkernagel AS,
    8. Entenza JM
    . 2013. Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis. Int J Med Microbiol 303:498–504. doi:10.1016/j.ijmm.2013.06.006.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Zbinden A,
    2. Bostanci N,
    3. Belibasakis GN
    . 2015. The novel species Streptococcus tigurinus and its association with oral infection. Virulence 6:177–182. doi:10.4161/21505594.2014.970472.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Zbinden A,
    2. Aras F,
    3. Zbinden R,
    4. Mouttet F,
    5. Schmidlin PR,
    6. Bloemberg GV,
    7. Bostanci N
    . 2014. Frequent detection of Streptococcus tigurinus in the human oral microbial flora by a specific 16S rRNA gene real-time TaqMan PCR. BMC Microbiol 14:231. doi:10.1186/s12866-014-0231-5.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Mahlen SD,
    2. Clarridge JE
    3rd. 2009. Oral abscess caused by Campylobacter rectus: case report and literature review. J Clin Microbiol 47:848–851. doi:10.1128/JCM.01590-08.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Park KS,
    2. Ki CS,
    3. Kang CI,
    4. Kim YJ,
    5. Chung DR,
    6. Peck KR,
    7. Song JH,
    8. Lee NY
    . 2012. Evaluation of the GenBank, EzTaxon, and BIBI services for molecular identification of clinical blood culture isolates that were unidentifiable or misidentified by conventional methods. J Clin Microbiol 50:1792–1795. doi:10.1128/JCM.00081-12.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Edgar RC
    . 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792–1797. doi:10.1093/nar/gkh340.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Mather CA,
    2. Rivera SF,
    3. Butler-Wu SM
    . 2014. Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols. J Clin Microbiol 52:130–138. doi:10.1128/JCM.01996-13.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Isaksson J,
    2. Rasmussen M,
    3. Nilson B,
    4. Stadler LS,
    5. Kurland S,
    6. Olaison L,
    7. Ek E,
    8. Herrmann B
    . 2015. Comparison of species identification of endocarditis associated viridans streptococci using rnpB genotyping and 2 MALDI-TOF systems. Diagn Microbiol Infect Dis 81:240–245. doi:10.1016/j.diagmicrobio.2014.12.007.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Eribe ER,
    2. Paster BJ,
    3. Caugant DA,
    4. Dewhirst FE,
    5. Stromberg VK,
    6. Lacy GH,
    7. Olsen I
    . 2004. Genetic diversity of Leptotrichia and description of Leptotrichia goodfellowii sp. nov., Leptotrichia hofstadii sp. nov., Leptotrichia shahii sp. nov., and Leptotrichia wadei sp. nov. Int J Syst Evol Microbiol 54:583–592. doi:10.1099/ijs.0.02819-0.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Deutscher M,
    2. Perlman DC
    . 2008. Why some injection drug users lick their needles: a preliminary survey. Int J Drug Policy 19:342–345. doi:10.1016/j.drugpo.2007.06.006.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Guarner C,
    2. Runyon BA,
    3. Young S,
    4. Heck M,
    5. Sheikh MY
    . 1997. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 26:1372–1378. doi:10.1016/S0168-8278(97)80474-6.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Runyon BA,
    2. Squier S,
    3. Borzio M
    . 1994. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 21:792–796. doi:10.1016/S0168-8278(94)80241-6.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Căruntu FA,
    2. Benea L
    . 2006. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, treatment. J Gastrointestin Liver Dis 15:51–56.
    OpenUrlPubMed
  19. 19.↵
    1. Madrid AM,
    2. Cumsille F,
    3. Defilippi C
    . 1997. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci 42:738–742. doi:10.1023/A:1018899611006.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Scarpellini E,
    2. Valenza V,
    3. Gabrielli M,
    4. Lauritano EC,
    5. Perotti G,
    6. Merra G,
    7. Dal Lago A,
    8. Ojetti V,
    9. Ainora ME,
    10. Santoro M,
    11. Ghirlanda G,
    12. Gasbarrini A
    . 2010. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol 105:323–327. doi:10.1038/ajg.2009.558.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Clarridge JE, III
    . 2004. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 17:840–862, table of contents. doi:10.1128/CMR.17.4.840-862.2004.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Clinical Significance and Characterization of Streptococcus tigurinus Isolates in an Adult Population
Lori Bourassa, J. E. Clarridge III
Journal of Clinical Microbiology Oct 2015, 53 (11) 3574-3579; DOI: 10.1128/JCM.01551-15

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Significance and Characterization of Streptococcus tigurinus Isolates in an Adult Population
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical Significance and Characterization of Streptococcus tigurinus Isolates in an Adult Population
Lori Bourassa, J. E. Clarridge III
Journal of Clinical Microbiology Oct 2015, 53 (11) 3574-3579; DOI: 10.1128/JCM.01551-15
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X